The dysregulation of NEU1 function has been implicated in cardiovascular pathologies including atherosclerosis [27], vascular plaque inflammation [26], myocardial infarction [54], myocardial hypertrophy [55], heart failure [56], and diabetic cardiomyopathy (DCM) [57]. Here, NEU1 is linked to cardiac hypertrophy.